Link to Andrew Griffiths Vaccine Update information


UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca

Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the Medical and Health Products Regulatory Authority [MHRA] confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine when asked to do so.

National protocol for COVID-19 Vaccine Moderna

COVID-19 vaccination and blood clotting

Coronavirus (COVID-19) vaccination statistics, plans and documentation

Coronavirus (COVID-19) vaccine adverse reactions

Regulatory approval of COVID-19 Vaccine Moderna

WHEN WILL I GET MY JAB - Sussex Health & Care partnership

- COVID-19 vaccine monitoring reports

- COVID-19: vaccine surveillance strategy

- UK COVID-19 vaccines delivery plan

Government publishes plan for the largest vaccination programme in British history

- National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant])

- COVID-19 vaccination: easy-read resources

- Moderna COVID-19 vaccine authorised by UK medicines regulator

- Prioritising the first COVID-19 vaccine dose: JCVI statement

- Letter to the profession from the UK Chief Medical Officers on the UK COVID-19 vaccination programmes

- JCVI issues advice on the AstraZeneca COVID-19 vaccine

- Regulatory approval of COVID-19 Vaccine AstraZeneca

- Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020

- Possible impact of the COVID-19 vaccination programme on adherence to rules and guidance about personal protective behaviours aimed at preventing spread of the virus, 17 December 2020

- Statement from the UK Chief Medical Officers on the prioritisation of first doses of COVID-19 vaccines

- Oxford University/AstraZeneca COVID-19 vaccine approved

- Oxford University/AstraZeneca vaccine authorised by UK medicines regulator

- National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

- Safety of COVID-19 vaccines when given in pregnancy

- COVID-19 vaccination programme

- Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer BioNTech vaccine

- COVID-19 vaccination: consent form and letter for adults

- News story June Raine: How we backed a COVID-19 vaccine before rest of the West

- COVID-19 vaccination: consent form and letter for healthcare workers

- COVID-19 vaccination: consent form and letter for social care staff

- COVID-19 vaccination: consent forms and letters for care home residents

- COVID-19 vaccination: why you are being asked to wait

- COVID-19 vaccination: what to expect after vaccination

- COVID-19 vaccination: a guide for social care staff

- COVID-19 vaccination: guide for healthcare workers

- COVID-19 vaccination: guide for older adults

- COVID-19 vaccination: women of childbearing age, currently pregnant, planning a pregnancy or breastfeeding

- Regulatory approval of Pfizer / BioNTech vaccine for COVID-19

- Priority groups for vaccinations - independent report

- COVID-19: the green book, chapter 14a

COVID-19: vaccinator competency assessment tool

- COVID-19: vaccination programme guidance for healthcare practitioners

- COVID-19 vaccination programme

- COVID-19: vaccinator training recommendations